Although some evidence from animal studies, clinical cases and genetic studies supports the hypothesis of overexpression of P-gp in the BBB as a cause of resistance to pharmacological treatment of epilepsy (Wang et al., 2016), the true implications of ABCB1-c.3435T>C polymorphism of the ABCB1 gene have not yet been explained. This evidence concerns the gene PGP and epilepsy.